VRCA SCHEDULE 13G/A: SEC filing
Affinity Asset Advisors, LLC and Michael Cho
Filed with the SEC on · accession 0001011438-26-000698
VRCA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of 865,488 shares (4.99%) of Verrica Pharmaceuticals common stock as of September 30, 2026, including 176,834 shares issuable upon exercise of warrants. The stock moved -4.3% by the first close after the filing.
Summary of the filing
Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of 865,488 shares (4.99%) of Verrica Pharmaceuticals common stock as of September 30, 2026, including 176,834 shares issuable upon exercise of warrants. The filing is a passive investment disclosure with no stated intent to influence control.
Key details
How VRCA stock reacted
Close before
$3.72
Nov 12, 2026
First close after
-4.30%
$3.56
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for VRCA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VRCA?
Click hereFrequently asked questions
What did VRCA file with the SEC on Nov 13, 2026?
VRCA filed a SCHEDULE 13G/A (SEC filing). Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of 865,488 shares (4.99%) of Verrica Pharmaceuticals common stock as of September 30, 2026, including 176,834 shares issuable upon exercise of warrants. The filing is a passive investment disclosure with no stated intent to influence control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did VRCA stock react to this filing?
VRCA closed at $3.72 before the filing and $3.56 on Nov 13, 2026 (-4.30%).
Other VRCA SEC filings
Get alerts when VRCA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days